Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACIP: Low molecular weight heparin for early intrauterine growth restriction
2017-001905-33Phase 3Active
- Sponsor
- Fundació Sant Joan de Déu
- Start
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of low molecular weight heparin calcium in intrauterine growth restriction (IUGR) (2 arms), sponsored by Fundació Sant Joan de Déu. Primary endpoint: Gestational age at birth. Started Jul 2017; status: active.
02
Drugs
low molecular weight heparin calcium
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on 2017-001905-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001905-33.